Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 49, Issue 20, Pages 6111-6119Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm0607193
Keywords
-
Categories
Ask authors/readers for more resources
Alzheimer's disease (AD) is pathologically characterized by the accumulation of amyloid plaques and neurofibrillary tangles in the brain, and thus, the in vivo imaging of plaques and tangles would be beneficial for the early diagnosis of AD. It has been suggested that 5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)1,4,6-heptatrien-3-one (curcumin) may be responsible for low age-adjusted prevalence of AD in India. In the present study, eight novel derivatives of curcumin and 4-(4-hydroxy-3-methoxyphenyl)-3-buten-2-one (dehydrozingerone) were synthesized and their binding affinities for beta-amyloid (A beta) aggregates were measured. Of these ligands, fluoropropyl-substituted curcumin (8) showed the highest binding affinity (K-i = 0.07 nM), and therefore, 8 was radiolabeled and evaluated as a potential probe for A beta plaque imaging. Partition coefficient measurement and biodistribution in normal mice demonstrated that [F-18]8 has a suitable lipophilicity and reasonable initial brain uptake. Metabolism studies also indicated that [F-18]8 is metabolically stable in the brain. These results suggest that [F-18]8 is a suitable radioligand for A beta plaque imaging.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available